Company

Harrow Health, Inc.

Headquarters: San Diego, CA, United States

Employees: 182

CEO: Mr. Mark L. Baum J.D.

NASDAQ: HROW +3.93%

Market Cap

$370.1 Million

USD as of Jan. 1, 2024

Market Cap History

Harrow Health, Inc. market capitalization over time

Evolution of Harrow Health, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Harrow Health, Inc.

Detailed Description

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Harrow Health, Inc. has the following listings and related stock indices.


Stock: NASDAQ: HROW wb_incandescent

Stock: FSX: 3IP wb_incandescent

Details

Headquarters:

12264 El Camino Real

Suite 350

San Diego, CA 92130

United States

Phone: 858 704 4040

Fax: 858 345 1745